StockComparison Logo
vs

GSK vs CME

Comparison between GSK Plc (GSK, Company) and CME Group Inc - Class A (CME, Company).

GSK is from the Healthcare sector, while CME is from the Financial Services sector.

5-Year PerformanceCME has outperformed GSK, delivering a return of +11.3% compared to +5.4%

GSK vs CME - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Market Cap
GSK
$103B
Winner
CME
$104B
Max Drawdown
Winner
GSK
64.03%
CME
77.97%
Sharpe Ratio
Winner
GSK
1.27
CME
0.04
5Y Beta
GSK
0.25
Winner
CME
-0.11
Industry
GSK
Drug Manufacturers - General
CME
Financial Data & Stock Exchanges
P/E Ratio
Winner
GSK
11.89
CME
25.64
Forward P/E
Winner
GSK
9.85
CME
23.47
PEG Ratio
Winner
GSK
0.10
CME
1.36
Dividend Yield
Winner
GSK
3.57%
CME
1.76%
5Y Dividends CAGR
GSK
-8.44%
Winner
CME
13.49%
5Y EPS CAGR
GSK
4.65%
Winner
CME
14.51%
Debt to Equity
GSK
106.74%
Winner
CME
0.00%
Free Cash Flow Yield
Winner
GSK
8.17%
CME
4.18%
P/S Ratio
Winner
GSK
3.10
CME
15.49
P/B Ratio
GSK
4.19
Winner
CME
3.90

GSK vs CME - Historical Returns

Returns include dividend reinvestment.

1M
GSK
-12.15%
Winner
CME
-7.12%
3M
GSK
-13.89%
Winner
CME
-6.23%
6M
Winner
GSK
+9.93%
CME
+4.67%
1Y
Winner
GSK
+42.14%
CME
+3.60%
5Y(CAGR)
GSK
+5.35%
Winner
CME
+11.30%
10Y(CAGR)
GSK
+4.24%
Winner
CME
+15.99%
Max(CAGR)
GSK
+3.02%
Winner
CME
+19.77%

GSK vs CME - Annual Returns (1999 - 2026)

Returns include dividend reinvestment.

YearGSKCME
2026+2.38%+6.83%
2025+50.62%+19.58%
2024-6.27%+16.19%
2023+9.25%+30.69%
2022-32.73%-21.87%
2021+23.62%+31.45%
2020-17.52%-6.86%
2019+30.36%+11.17%
2018+9.29%+33.27%
2017-3.80%+33.42%
2016+1.52%+36.85%
2015+0.48%+8.30%
2014-14.73%+19.08%
2013+26.97%+61.87%
2012-0.75%+10.43%
2011+22.51%-21.38%
2010-3.72%-4.57%
2009+20.27%+60.84%
2008-21.93%-68.28%
2007-2.77%+31.94%
2006+6.93%+41.19%
2005+9.96%+69.85%
2004+5.08%+216.18%
2003+25.04%+67.26%
2002-22.83%+1.77%
2001-9.58%N/A
2000+5.67%N/A
1999-5.78%N/A

GSK vs CME Drawdown Comparison

The maximum drawdown for GSK was -50.11%, occurring on Sep 27, 2022. Recovery took 935 trading sessions.

The maximum drawdown for CME was -77.49%, occurring on Nov 20, 2008. Recovery took 2170 trading sessions.

The current GSK drawdown is -16.95%. The current CME drawdown is -11.75%.

RankGSKCME
#1-50.11%
Apr 13, 2022 - Jan 6, 2026
-77.49%
Dec 21, 2007 - Aug 5, 2016
#2-49.64%
Apr 20, 2007 - Apr 18, 2012
-37.34%
Mar 4, 2020 - May 14, 2021
#3-45.23%
Apr 25, 2000 - Nov 11, 2005
-31.74%
Mar 21, 2022 - Oct 16, 2024
#4-32.56%
Jan 17, 2020 - Dec 10, 2021
-25.44%
Dec 31, 2004 - Jun 2, 2005
#5-27.97%
Mar 4, 2014 - Sep 3, 2019
-20.44%
Jul 1, 2004 - Sep 21, 2004
#6-26.98%
Nov 5, 1999 - Apr 11, 2000
-17.07%
Jul 23, 2003 - Jan 16, 2004
#7-16.98%
Feb 18, 2026 - May 5, 2026
-16.36%
Jan 13, 2003 - Apr 22, 2003
#8-14.45%
Jan 18, 2022 - Apr 7, 2022
-15.69%
Jan 24, 2007 - Aug 8, 2007
#9-10.52%
May 16, 2006 - Feb 13, 2007
-15.42%
Nov 16, 2018 - May 30, 2019
#10-10.48%
Oct 4, 2012 - Mar 22, 2013
-14.69%
Jun 16, 2021 - Oct 22, 2021
#11-8.45%
May 28, 2013 - Nov 1, 2013
-13.92%
Aug 2, 2005 - Sep 16, 2005
#12-8.43%
Apr 11, 2000 - Apr 25, 2000
-13.60%
Jul 5, 2006 - Oct 9, 2006
#13-8.16%
Nov 11, 2005 - Mar 8, 2006
-13.39%
Apr 21, 2006 - Jul 5, 2006
#14-7.54%
Feb 14, 2007 - Apr 16, 2007
-12.48%
Aug 8, 2007 - Oct 1, 2007
#15-7.37%
Jan 21, 2014 - Feb 13, 2014
-12.46%
Nov 25, 2005 - Jan 24, 2006

Correlation

Correlation between GSK and CME is 0.81 which considered as a strong positive correlation - the stocks tend to move together.

0.81
-101

Dividend Comparison (2000 - 2026)

GSK vs CME dividend yield comparison.

YearGSKCME
20260.96%2.65%
20253.42%1.83%
20244.60%4.48%
20233.75%4.58%
20225.47%5.05%
20214.99%3.00%
20205.59%3.24%
20194.35%2.74%
20185.65%2.42%
20175.83%4.20%
20166.86%4.90%
20155.93%5.41%
20146.20%4.38%
20134.51%5.61%
20125.70%7.29%
20114.83%2.30%
20105.10%1.43%
20094.39%1.37%
20085.74%4.61%
20074.09%0.50%
20063.29%0.49%
20053.03%0.50%
20043.38%0.45%
20032.77%0.87%
20023.10%0.00%
20011.54%0.00%
20004.57%0.00%

Select Stocks to Compare